NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON

Partner Testing Labs

Finnrick works with several independent analytical laboratories to test peptide samples we list on the site. Each lab uses its own validated analytical workflow, instrumentation, and reporting conventions.

To improve transparency, Finnrick asked participating labs to answer a short methodology questionnaire covering topics such as calibration, sample preparation, quantification method, and stated uncertainty. Their responses are published below so readers can better understand how each lab generates its results.

Finnrick evaluates laboratory performance empirically by analyzing large numbers of overlapping tests — cases where multiple labs analyze samples from the same batch. By examining distributions across hundreds of such comparisons, we can estimate whether a lab tends to report systematically higher or lower quantities, and whether its results are consistent relative to peers.

This page provides context for:

  • How each lab says it performs its measurements
  • How those measurements compare to other labs in practice
  • How Finnrick evaluates lab performance using aggregated data
Published tests by lab
LabTestsEarliestLatest
Krause Analytical7,32824 Apr 202524 Sep 2026
BTLabs2,89322 Jul 202524 Sep 2026
Chromate68117 Dec 202414 Jul 2026
TrustPointe31513 Feb 20258 May 2025
Freedom Diagnostics22525 Apr 202513 Sep 2025
Janoshik20014 Apr 20259 Sep 2025
MZ Biolabs17923 Jan 202529 Sep 2025
Ichor Life Sciences7015 Jul 202621 Sep 2026
Harrens Lab6115 Sep 202625 Sep 2026
PharmLabs473 Sep 202620 Sep 2026

Test counts are for published tests. Linked lab names open their testing pages; the icon appears when a methodology questionnaire is available.

Methodology Questionnaire

Finnrick sent participating labs the following ten questions about their analytical workflow. Click the document icon next to a lab in the table above to read its responses; the lab name opens its testing page.

A

Quantification Basis

  1. Is reported quantity based on absolute calibration against a reference standard, or relative/normalized signal?
  2. Do you average replicate injections or preparations before reporting a single value?
B

Sample Preparation

  1. Do you assume full recovery of peptide upon reconstitution, or do you measure recovery implicitly?
  2. Do you correct for adsorption, losses, or degradation, or are these reflected in the final number?
C

Detection & Calculation

  1. Which detector(s) are used for quantification (UV, MS, both), and which signal is authoritative for quantity?
  2. How is purity incorporated into quantity (e.g., normalization vs independent measurement)?
D

Precision & Uncertainty

  1. What is your stated margin of error for this peptide, and does it include preparation + calibration uncertainty?
  2. Are reported values rounded, truncated, or raw calculated outputs?
E

Interpretation

  1. Does your reported “mg per vial” represent recovered mass, inferred mass, or label-equivalent mass?
  2. Under what conditions would you expect two vials from the same batch to differ by <1%?

Do you distribute peptides?

Finnrick offers professional testing services for vendors who want to verify their supply chain and build trust with customers through independent quality assurance.

Learn about vendor services